| A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed (NCT05422326) | Seqirus | 2022-07-18 |
| Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (NCT03392207) | Butantan Institute | 2018-04-23 |
| Centralized Reminder Recall - Flu RCT2 (NCT03294473) | University of California, Los Angeles | 2017-10-18 |
| DNA-based Influenza Vaccine in the Elderly (NCT01587131) | University of Manitoba | 2012-06-01 |
| Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients (NCT01055990) | Shanghai Public Health Clinical Center | 2009-10-01 |
| Safety of H1N1 Influenza Vaccination in Pregnant Women (NCT01842997) | Jiangsu Province Centers for Disease Control and Prevention | 2009-10-01 |
| Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older (NCT00975572) | Jiangsu Province Centers for Disease Control and Prevention | 2009-07-01 |
| Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children (NCT00884182) | Sanofi Pasteur, a Sanofi Company | 2009-04-01 |
| Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone® (NCT00755274) | Sanofi Pasteur, a Sanofi Company | 2008-09-01 |
| Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (NCT00718146) | Sanofi Pasteur, a Sanofi Company | 2008-06-01 |
| Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine (NCT00664417) | Sanofi | 2008-04-01 |
| Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects (NCT00606359) | Sanofi Pasteur, a Sanofi Company | 2007-11-01 |
| Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults (NCT00545701) | Sanofi Pasteur, a Sanofi Company | 2007-10-01 |
| Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children (NCT00491985) | Sanofi Pasteur, a Sanofi Company | 2007-06-01 |
| A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine (NCT00343681) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |
| Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly (NCT00415129) | Sanofi Pasteur, a Sanofi Company | 2006-06-01 |
| Immunogenicity Study of the Influenza Vaccine in Adults (NCT00258934) | Sanofi Pasteur, a Sanofi Company | 2005-09-01 |